|
|
|
|
||
Re: CC - Top Ten Questions and Answers10. What did you accomplish last quarter? -- We were able to all stay employed despite no accomplishments. 9. What plans do you have for current quarter? -- Happy to report we have reached our goal early in the quarter with issuance of stock options to key performers in the company. 8. Why have no partner drugs advanced generating a milestone payments? Thats a great question and maybe one we should have asked our partners. However it might be best if you asked them. 7. Why have you announced no results in for your in house trials? -- Charlie do you want to take that one. Well (says Charlie) there really have been no results other than those already announced. 6. Follow-up to that answer Charlie. Perhaps I missed something but I don't recall any results that have been announced? -- That would be a correct assessment on your part. 5. How is the cash position? While we have more than enough to meet nearby demand for cash we do feel cash burn will increase as we grant raises to everyone and hire more folks to do what ever it is we do. So look forward to a secondary this quarter. Sorry I did not mention that in connection with earlier question about current plans. 4. What are your projections for royalty payments from Kadcyla? -- As you know we do not share those projections, besides we have not really made any internally. That probably is a question you should ask Roche. 3. Dan, since you are joining the Boards of some other companies, won't that impact the time you spend on IMGN? -- Absolutely not. I have plenty of free time while managing IMGN. 2. Is there anything at all you can tell us about on-going trials? -- Sure we are seeing a great deal of safety at current dosing levels. 1. How do you guys stay employed? -- Good question. That's probably better directed at our shareholders, but to be honest they appear to enjoy being screwed. |
return to message board, top of board |